Johnson & Johnson COVID-19 Vaccine Not ‘Preferred’ Due to Link to Severe Condition: CDC Advisers

CDC director endorsed recommendation

A nurse fills a syringe with Johnson & Johnson's COVID-19 vaccine in Pasadena, Calif., on Aug. 19, 2021. Robyn Beck/AFP via Getty Images

A panel of advisers to the Centers for Disease Control and Prevention (CDC) unanimously voted on Thursday to recommend the agency tell the public that the Moderna and Pfizer COVID-19 vaccines are preferred to the jab from Johnson & Johnson (J&J).

“mRNA COVID-19 vaccines are preferred over the Janssen COVID-19 vaccine for the prevention of COVID-19 for all ≥ 18 years of age,” the recommendation states.